Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Testosterone's effects on COVID-19 are unclear and need more research.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

2021 saw a slow return to normalcy and increased scientific engagement despite COVID-19 challenges.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

More research is needed to understand sex and racial differences in long COVID.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Covid-19 can cause different types of hair loss, which can affect people's mental and social well-being.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Countries with stricter cultures had fewer COVID-19 cases and deaths, paranoia is linked to false memories, psychosocial intervention works as well with or without antipsychotic drugs for young people with psychosis, smartphones can detect changes in behavior indicating illness relapse, and recruitment agents show regional and gender biases.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

The editorial stresses the importance of COVID-19 vaccination and ongoing contributions to the journal.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

Microneedles are effective for drug delivery, vaccinations, fluid extraction, and treating hair loss, with advancements in manufacturing like 3D printing.